These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 30815845)
61. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Liao JF; Cheng YF; You ST; Kuo WC; Huang CW; Chiou JJ; Hsu CC; Hsieh-Li HM; Wang S; Tsai YC Brain Behav Immun; 2020 Nov; 90():26-46. PubMed ID: 32739365 [TBL] [Abstract][Full Text] [Related]
62. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis. Zhu Y; Huan F; Wang J; Xie X; Yu G; Wang X; Jiang L; Gao R; Xiao H; Ding H; Wang J ACS Chem Neurosci; 2020 Oct; 11(20):3366-3376. PubMed ID: 32926778 [TBL] [Abstract][Full Text] [Related]
63. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease. Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664 [TBL] [Abstract][Full Text] [Related]
64. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model. Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901 [TBL] [Abstract][Full Text] [Related]
65. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448 [TBL] [Abstract][Full Text] [Related]
66. Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model. Chen Z; He S; Wei Y; Liu Y; Xu Q; Lin X; Chen C; Lin W; Wang Y; Li L; Xu Y Front Cell Infect Microbiol; 2023; 13():1150043. PubMed ID: 37180443 [TBL] [Abstract][Full Text] [Related]
67. Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics. Lu Y; Gao X; Mohammed SAD; Wang T; Fu J; Wang Y; Nan Y; Lu F; Liu S J Ethnopharmacol; 2024 Jan; 319(Pt 1):117182. PubMed ID: 37714224 [TBL] [Abstract][Full Text] [Related]
68. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response. Chetia Phukan B; Dutta A; Deb S; Saikia R; Mazumder MK; Paul R; Bhattacharya P; Sandhir R; Borah A Exp Brain Res; 2022 Jan; 240(1):113-122. PubMed ID: 34633467 [TBL] [Abstract][Full Text] [Related]
69. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease. Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264 [TBL] [Abstract][Full Text] [Related]
70. Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway. Hang W; Fan HJ; Li YR; Xiao Q; Jia L; Song LJ; Gao Y; Jin XM; Xiao BG; Yu JZ; Ma CG; Chai Z Metab Brain Dis; 2022 Jun; 37(5):1435-1450. PubMed ID: 35488941 [TBL] [Abstract][Full Text] [Related]
71. Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice. Yang H; Shao Y; Hu Y; Qian J; Wang P; Tian L; Ni Y; Li S; Al-Nusaif M; Liu C; Le W CNS Neurosci Ther; 2024 Aug; 30(8):e70003. PubMed ID: 39161161 [TBL] [Abstract][Full Text] [Related]
72. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. Srivastav S; Neupane S; Bhurtel S; Katila N; Maharjan S; Choi H; Hong JT; Choi DY J Nutr Biochem; 2019 Jul; 69():73-86. PubMed ID: 31063918 [TBL] [Abstract][Full Text] [Related]
73. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269 [TBL] [Abstract][Full Text] [Related]
76. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease. Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843 [TBL] [Abstract][Full Text] [Related]
77. Neuroprotection by freshwater clam extract against the neurotoxin MPTP in C57BL/6 mice. Hsieh CC; Lin MS; Hua KF; Chen WJ; Lin CC Neurosci Lett; 2017 Mar; 642():51-58. PubMed ID: 28126590 [TBL] [Abstract][Full Text] [Related]
78. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF. Ji C; Xue GF; Lijun C; Feng P; Li D; Li L; Li G; Hölscher C Brain Res; 2016 Mar; 1634():1-11. PubMed ID: 26453833 [TBL] [Abstract][Full Text] [Related]
79. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota. Zhang Y; Xu S; Qian Y; Mo C; Ai P; Yang X; Xiao Q Front Aging Neurosci; 2023; 15():1099018. PubMed ID: 36761177 [TBL] [Abstract][Full Text] [Related]
80. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP Luo D; Zhao J; Cheng Y; Lee SM; Rong J Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]